Size: 5mg
Contents: Tirzepatide (5mg)
Form: Lyophilized powder
Purity: >99%
Tirzepatide 5mg is a synthetic, research-grade peptide classified as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is developed for in-vitro and preclinical research applications focused on metabolic regulation, endocrine signaling, and energy homeostasis. This peptide is designed to interact with incretin receptors involved in glucose metabolism and insulin secretion.
Through its dual receptor activity, Tirzepatide 5mg is widely studied for its potential ability to influence metabolic pathways related to insulin response, body weight regulation, and nutrient utilization. Its unique mechanism as a twin-incretin mimetic makes it a valuable compound in controlled laboratory research environments.
Tirzepatide 5mg is recognized in research for its dual action on both GIP and GLP-1 receptors, making it distinct from single-pathway peptides. It is commonly studied for its role in modulating glucose metabolism, insulin secretion, and appetite-related signaling pathways.
Research suggests that its interaction with incretin systems may contribute to improved metabolic efficiency and regulation of energy balance. Because of these properties, Tirzepatide is frequently explored in studies involving metabolic syndrome, adipogenesis, and pancreatic beta-cell function.
Peptide Type: Dual incretin receptor agonist
Target Receptors: GIP and GLP-1 receptors
Function: Metabolic regulation and insulin signaling research
Research suggests that Tirzepatide 5mg may function by binding to both GIP and GLP-1 receptors, activating signaling pathways associated with glucose metabolism and insulin secretion.
This dual receptor activation may enhance insulin response while also influencing pathways related to appetite regulation and energy utilization. These processes are believed to involve intracellular signaling cascades that support glucose homeostasis and metabolic balance, making it a key focus in metabolic research studies.
Tirzepatide 5mg is commonly utilized in laboratory studies focused on:
Its dual incretin activity makes it a widely studied compound in advanced metabolic and endocrine research models.
In controlled research environments, Tirzepatide has been associated with significant effects on glucose regulation and metabolic signaling pathways. Studies suggest that its dual receptor activity may provide enhanced modulation of insulin response compared to single-receptor agonists.
Researchers continue to investigate its broader role in energy homeostasis, weight regulation, and pancreatic function, making it an important compound in ongoing metabolic and endocrine research.
Product Name: Tirzepatide
Quantity: 5mg per vial
Form: Lyophilized powder
Purity: ≥99%
Store Tirzepatide 5mg in a cool, dry place away from direct light. Refrigeration is recommended to maintain stability, especially after reconstitution in research settings.
Tirzepatide 5mg is intended strictly for research and laboratory use only. It is not approved for human consumption, veterinary use, or therapeutic applications. All handling must be performed by qualified professionals in accordance with applicable laws and regulations.
